Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Sorbonne Université · Hôpital Tenon · +10 more institutions
Indexed incrossrefpubmed
Abstract
Background
The standard adjuvant treatment of colon cancer is fluorouracil plus leucovorin (FL). Oxaliplatin improves the efficacy of this combination in patients with metastatic colorectal cancer. We evaluated the efficacy of treatment with FL plus oxaliplatin in the postoperative adjuvant setting.
Methods
We randomly assigned 2246 patients who had undergone curative resection for stage II or III colon cancer to receive FL alone or with oxaliplatin for six months. The primary end point was disease-free survival.
Citation impact
3,646
total citations
- FWCI
- 81.39
- Percentile
- 100%
- References
- 27
Citations per year
Authors
12Topics & keywords
Topics
Keywords
- Medicine
- Oxaliplatin
- Internal medicine
- Hazard ratio
- Colorectal cancer
- Gastroenterology
- Fluorouracil
- Surgery
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.